Paragon 28 Launches R3ACT Ankle Stabilization

By Julie A. Vetalice

Paragon 28 Launches R3ACT Ankle Stabilization

Paragon 28 introduced its R3ACT™ Stabilization System, designed to allow for multi-stage soft tissue healing following an acute or chronic syndesmotic injury to the ankle.

The system received FDA 510(k) marketing clearance in January 2022.

Paragon 28’s CEO, Albert DaCosta, said, “Since the inception of Paragon 28, the development of a syndesmotic stabilization system for ankle injuries has been a top priority for us. We believe this unique and proprietary product addresses the complexities of this indication and mimics not only the dynamic environment, but also transitions the function of stabilization to best match the healing phases of the soft tissues.

"Approximately 20% of all ankle injuries require implants for soft tissue healing. As a result, we believe the R3ACT™ Stabilization System will be a nice complement to our entire ankle fracture portfolio.”

Source: Paragon 28, Inc.

Product Labels: Trauma Ankle/Foot/Toe

Tags: Product Launch